Abstract
Mesenchymal stem cells (MSCs) are multi-potent cells which have been widely used for tissue regeneration and immunomodulation. The infusion of autologous and allogenic MSCs has been proved to be safe and effective in tissue repair and disease modulation. The inherent homing ability of MSCs ensures the transplanted cells migrating into the damaged tissue areas, but only a small percentage of the transplanted (allogenic) MSCs survive for long. However, the beneficial effects of MSCs transplantation could be noted within 1-2 days that are unlikely due to their proliferation and differentiation. The regulatory roles of MSCs in tissue repair are rather more important than their direct involvement of repair processes. The most important effect of transplanted MSCs is their immunomodulation function through crosstalk with the immune cells or the paracrine actions. The active factor secreted by MSCs may vary in the different disease conditions or tissue niches, and are under dynamic changes in various local environments. To understand and define the MSCs secretion factors in various disease settings could be a future research direction, and the findings could lead to potential new MSCs-based therapeutic products.
Keywords: Fate, immunomodulation, mesenchymal stem cells (MSCs), secretive factors, transplantation.
Current Stem Cell Research & Therapy
Title:The Roles of Mesenchymal Stem Cells in Tissue Repair and Disease Modification
Volume: 9 Issue: 5
Author(s): Tianyi Wu, Yang Liu, Bin Wang and Gang Li
Affiliation:
Keywords: Fate, immunomodulation, mesenchymal stem cells (MSCs), secretive factors, transplantation.
Abstract: Mesenchymal stem cells (MSCs) are multi-potent cells which have been widely used for tissue regeneration and immunomodulation. The infusion of autologous and allogenic MSCs has been proved to be safe and effective in tissue repair and disease modulation. The inherent homing ability of MSCs ensures the transplanted cells migrating into the damaged tissue areas, but only a small percentage of the transplanted (allogenic) MSCs survive for long. However, the beneficial effects of MSCs transplantation could be noted within 1-2 days that are unlikely due to their proliferation and differentiation. The regulatory roles of MSCs in tissue repair are rather more important than their direct involvement of repair processes. The most important effect of transplanted MSCs is their immunomodulation function through crosstalk with the immune cells or the paracrine actions. The active factor secreted by MSCs may vary in the different disease conditions or tissue niches, and are under dynamic changes in various local environments. To understand and define the MSCs secretion factors in various disease settings could be a future research direction, and the findings could lead to potential new MSCs-based therapeutic products.
Export Options
About this article
Cite this article as:
Wu Tianyi, Liu Yang, Wang Bin and Li Gang, The Roles of Mesenchymal Stem Cells in Tissue Repair and Disease Modification, Current Stem Cell Research & Therapy 2014; 9 (5) . https://dx.doi.org/10.2174/1574888X09666140616125446
DOI https://dx.doi.org/10.2174/1574888X09666140616125446 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Insulin Resistance, Oxidative Stress and Cardiovascular Complications: Role of Sirtuins
Current Pharmaceutical Design New Heterocyclic Compounds: Synthesis, Antioxidant Activity and Computational Insights of Nano-Antioxidant as Ascorbate Peroxidase Inhibitor by Various Cyclodextrins as Drug Delivery Systems
Current Drug Delivery Diabetes and Heart Failure: Is it Hyperglycemia or Hyperinsulinemia?
Current Vascular Pharmacology Therapeutic Approaches Targeting Pathological Tau Aggregates
Current Pharmaceutical Design Gene Therapy to Improve High-Density Lipoprotein Metabolism and Function
Current Pharmaceutical Design Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Host Innate Immune Responses to Microbial Pathogens
Current Vascular Pharmacology Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias
Current Cardiology Reviews Biomarkers in Cardiomyopathies and Prediction of Sudden Cardiac Death
Current Pharmaceutical Biotechnology Bcl-2 Family Proteins Regulate Apoptosis and Epithelial to Mesenchymal Transition by Calcium Signals
Current Pharmaceutical Design Methods to Evaluate the Inhibition of TTR Fibrillogenesis Induced by Small Ligands
Current Medicinal Chemistry The Right Ventricle: Biologic Insights and Response to Disease
Current Cardiology Reviews Non Invasive Imaging of Myocardial Infarction with Computed Tomography and Magnetic Resonance
Current Vascular Pharmacology Autophagy: A Major Target of Cadmium Nephrotoxicity
Current Chemical Biology Functional Variants of the Interleukin-23 Receptor Gene in Non-Gastrointestinal Autoimmune Diseases
Current Medicinal Chemistry Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges
Current Medicinal Chemistry Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
Recent Advances in Cardiovascular Drug Discovery (Discontinued) The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Current Pharmaceutical Design The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis
Current Medical Imaging